©The Author(s) 2026.
World J Hepatol. Jan 27, 2026; 18(1): 114542
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.114542
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.114542
Table 2 Serum alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and bilirubin in different hamster groups, mean ± SD
| Control negative group I | Control negative ZSCLE-treated group II | Infected BLV group III | Infected BLV and ZSCLE-treated group IV | Infected BLZ, ZSCLE-treated, and 50% resected group V | P value | |
| Serum ALT (U/L) | 27.01 ± 2.86 | 29.01 ± 3.75 | 87.44 ± 2.62a,b | 39.90 ± 2.62a,b,c | 38.08 ± 2.09a,b,c | < 0.0001 |
| Serum AST (U/L) | 30.75 ± 1.07 | 31.58 ± 0.96 | 99.85 ± 2.17a,b | 42.44 ± 1.96a,b,c | 41.18 ± 2.10a,b,c | < 0.0001 |
| Serum ALP (U/L) | 65.69 ± 1.63 | 68.35 ± 1.99 | 144.41 ± 2.39a,b | 79.72 ± 4.45a,b,c | 77.45 ± 1.39a,b,c | < 0.0001 |
| Serum bilirubin (mg/dL) | 0.22 ± 0.03 | 0.26 ± 0.03 | 0.93 ± 0.05a,b | 0.41 ± 0.03a,b,c | 0.39 ± 0.05a,b,c | < 0.0001 |
- Citation: Alghamdi TH. Enhanced surgical tolerance of schistosomiasis-induced fibrotic liver following treatment with Ziziphus plant extract. World J Hepatol 2026; 18(1): 114542
- URL: https://www.wjgnet.com/1948-5182/full/v18/i1/114542.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i1.114542